Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Warfarin

Warfarin Reactions 1704, p373 - 2 Jun 2018 Lobar intracerebral haemorrhage: case report An 86-year-old woman developed lobar intracerebral haemorrhage during treatment with warfarin [coumadin; dosage, route, time to reaction onset and outcome not stated]. The woman had a history of multiple deep vein thrombosis and heterozygous for Factor V Leiden and prothrombin gene mutations. She had been receiving anticoagulation therapy with warfarin. She presented to the emergency department with right arm weakness and aphasia. She was found to have intracerebral haemorrhage with intraventricular extension as revealed by head CT. The woman received prothrombin complex concentrate [Kcentra] to reverse anticoagulation. An MRI revealed approximately 50 micro-bleeds with primarily lobar distribution, consistent with underlying cerebral amyloid angiopathy. Lower extremity non-invasive study showed a non-occlusive thrombus in the left femoral and popliteal veins. The treatment with warfarin was discontinued due to the high risk of recurrent intracranial haemorrhage. She was initiated on prophylactic dosing of enoxaparin sodium [lovenox]. Author comment: "Case presentation of lobar intracerebral haemorrhage in a patient with inherited hyper- coagulable state on systemic anticoagulation with underlying CAA." Li M, et al. The complex dilemma- Decision for anticoagulation in cerebral amyloid angiopathy (CAA) with microbleeds. Journal of the American Geriatrics http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Warfarin

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Download PDF
1 page

Warfarin

Abstract

Reactions 1704, p373 - 2 Jun 2018 Lobar intracerebral haemorrhage: case report An 86-year-old woman developed lobar intracerebral haemorrhage during treatment with warfarin [coumadin; dosage, route, time to reaction onset and outcome not stated]. The woman had a history of multiple deep vein thrombosis and heterozygous for Factor V Leiden and prothrombin gene mutations. She had been receiving anticoagulation therapy with warfarin. She presented to the emergency department with right arm...
Loading next page...
 
/lp/springer_journal/warfarin-qt07y3mN0h
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-018-47016-7
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p373 - 2 Jun 2018 Lobar intracerebral haemorrhage: case report An 86-year-old woman developed lobar intracerebral haemorrhage during treatment with warfarin [coumadin; dosage, route, time to reaction onset and outcome not stated]. The woman had a history of multiple deep vein thrombosis and heterozygous for Factor V Leiden and prothrombin gene mutations. She had been receiving anticoagulation therapy with warfarin. She presented to the emergency department with right arm weakness and aphasia. She was found to have intracerebral haemorrhage with intraventricular extension as revealed by head CT. The woman received prothrombin complex concentrate [Kcentra] to reverse anticoagulation. An MRI revealed approximately 50 micro-bleeds with primarily lobar distribution, consistent with underlying cerebral amyloid angiopathy. Lower extremity non-invasive study showed a non-occlusive thrombus in the left femoral and popliteal veins. The treatment with warfarin was discontinued due to the high risk of recurrent intracranial haemorrhage. She was initiated on prophylactic dosing of enoxaparin sodium [lovenox]. Author comment: "Case presentation of lobar intracerebral haemorrhage in a patient with inherited hyper- coagulable state on systemic anticoagulation with underlying CAA." Li M, et al. The complex dilemma- Decision for anticoagulation in cerebral amyloid angiopathy (CAA) with microbleeds. Journal of the American Geriatrics

Journal

Reactions Weekly – Springer Journals

Published: Jun 2, 2018

There are no references for this article.